BioCentury
ARTICLE | Clinical News

Beta LT: Began Phase I/II testing

August 28, 2000 7:00 AM UTC

LifeTime Pharmaceuticals Inc., Silver Spring, Md. Product: Beta LT Business: Cancer Therapeutic category: Immune stimulation Target: Lymphocytes Description: Beta-alethine immune stimulant Indication...